Jackson Square Capital LLC Buys Shares of 3,252 Astera Labs, Inc. $ALAB

Key Points

• Jackson Square Capital LLC has taken a new position in Astera Labs, purchasing 3,252 shares valued at approximately $294,000 during the second quarter.
• Several institutional investors have increased their stakes in Astera Labs, with notable increases from Fred Alger Management LLC (13%) and UBS AM (2,824.4%).
• Astera Labs reported a substantial 149.5% increase in quarterly revenue compared to the previous year, achieving $191.93 million, and exceeded EPS estimates by $0.11.

Jackson Square Capital LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,252 shares of the company's stock, valued at approximately $294,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Fred Alger Management LLC lifted its stake in shares of Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock valued at $93,087,000 after purchasing an additional 179,638 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Astera Labs by 2,824.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock valued at $20,467,000 after acquiring an additional 149,240 shares in the last quarter. Aigen Investment Management LP increased its holdings in Astera Labs by 50.9% during the 1st quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock valued at $1,069,000 after acquiring an additional 6,045 shares in the last quarter. Pacific Point Advisors LLC increased its holdings in Astera Labs by 75.0% during the 1st quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company's stock valued at $418,000 after acquiring an additional 3,000 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in Astera Labs by 73.6% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company's stock valued at $954,000 after acquiring an additional 6,783 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Wall Street Zen upgraded shares of Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday, August 16th. Citigroup lifted their price target on shares of Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a report on Wednesday. Evercore ISI lifted their price target on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, August 6th. Jefferies Financial Group boosted their target price on shares of Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Finally, CICC Research started coverage on shares of Astera Labs in a report on Friday, August 29th. They issued an "outperform" rating and a $190.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Astera Labs currently has a consensus rating of "Moderate Buy" and a consensus target price of $152.94.

Astera Labs Price Performance

ALAB stock traded down $6.68 during midday trading on Friday, reaching $245.20. 22,431,313 shares of the company's stock traded hands, compared to its average volume of 4,617,677. The company has a market capitalization of $40.76 billion, a P/E ratio of 437.86, a PEG ratio of 6.39 and a beta of 1.48. Astera Labs, Inc. has a fifty-two week low of $47.00 and a fifty-two week high of $262.90. The business has a 50-day moving average price of $169.95 and a two-hundred day moving average price of $109.51.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The firm had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs's revenue was up 149.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Jitendra Mohan sold 152,517 shares of the firm's stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the completion of the sale, the chief executive officer owned 450,001 shares of the company's stock, valued at approximately $76,648,670.33. This trade represents a 25.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the sale, the director owned 385,863 shares of the company's stock, valued at approximately $66,858,482.01. This trade represents a 32.17% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,576,713 shares of company stock valued at $239,237,016. Corporate insiders own 12.50% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.